Tag: M.W=300-350

Kaewchuay, Netnapit published the artcileA novel hybrid mode of sample injection to enhance CZE sensitivity for simultaneous determination of a pyridine-triphenylborane anti-fouling agent and its degradation products, Synthetic Route of 971-66-4, the publication is Electrophoresis (2011), 32(12), 1486-1491, database is CAplus and MEDLINE.

We developed a novel hybrid sample injection mode (HSIM) that presents the combination of electrokinetic injection and vacuum injection to enhance detection sensitivity in CZE. Samples were introduced using both vacuum and electrokinetic injections simultaneously, with a water plug injected into the capillary prior to sample introduction (i.e. similarly to field-amplified sample injection, FASI). Using a sample mixture containing an anti-fouling agent applied to ship hulls, pyridine-triphenylborane and its degradation products (diphenylborinic acid, phenylboronic acid, and phenol) dissolved in ACN, the length of water plug, time, and voltage for sample introduction were optimized. The signal intensity (peak height) was found to be up to a 30-fold increased using HSIM by applying 4 kV for 4 s at the inlet end of the capillary as the cathode with supplementary vacuum in comparison with only vacuum injection for 4 s. The LODs (at a S/N of 3) for pyridine-triphenylborane, diphenylborinic acid, phenylboronic acid, and phenol were 0.88, 1.0, 21, and 23 μg/L, resp. At the level of 0.04 mg/L, the RSDs (n=4, intra-day) for the above analytes were in the ranges of 1.9-11, 4.3-9.2, and 0.34-0.66% for peak area, peak height, and migration time, resp. The HSIM is a simple and promising procedure useful for enhancing the sensitivity for both low-and high-mobility ions in CZE.

Electrophoresis published new progress about 971-66-4. 971-66-4 belongs to pyridine-derivatives, auxiliary class Pyridine,Benzene, name is Triphenyl(pyridin-1-ium-1-yl)borate, and the molecular formula is C23H20BN, Synthetic Route of 971-66-4.

Referemce:
https://en.wikipedia.org/wiki/Pyridine,
Pyridine | C5H5N – PubChem

Mikami, Eiichi published the artcileRapid determination of drugs in pharmaceutical preparations by liquid chromatography. (III). Determination of todralazine hydrochloride, trimetoquinol hydrochloride, nicardipine hydrochloride, sulpiride, furosemide and betahistine mesilate in pharmaceutical preparations, Formula: C10H20N2O6S2, the publication is Iyakuhin Kenkyu (1992), 23(6), 896-901, database is CAplus.

Liquid chromatog. methods using UV detection are described for determination of the title drugs in pharmaceutical preparations Stationary phase was Wakosil 5C18. Internal standards were p-hydroxybenzoic acid (for todralazine hydrochloride and sulpiride), Me p-aminobenzoate (for trimetoquinol hydrochloride and betahistidine mesilate), Pr p-hydroxybenzoate (for nicardipine hydrochloride), and Pr p-aminobenzoate (for furosemide). These rapid methods are useful for anal. for com. pharmaceutical preparations

Iyakuhin Kenkyu published new progress about 54856-23-4. 54856-23-4 belongs to pyridine-derivatives, auxiliary class Pyridine,Salt,Amine,Inhibitor,Inhibitor, name is N-Methyl-2-(pyridin-2-yl)ethan-1-amine dimethanesulfonate, and the molecular formula is C10H20N2O6S2, Formula: C10H20N2O6S2.

Referemce:
https://en.wikipedia.org/wiki/Pyridine,
Pyridine | C5H5N – PubChem

Motomura, Naoki published the artcileVisualization of calcium channel blockers in human adrenal tissues and their possible effects on steroidogenesis in the patients with primary aldosteronism (PA), Recommanded Product: Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, the publication is Journal of Steroid Biochemistry and Molecular Biology (2022), 106062, database is CAplus and MEDLINE.

Voltage-gated L-type calcium channel (CaV) isoforms are well known to play pivotal tissue-specific roles not only in vasoconstriction but also in adrenocortical steroidogenesis including aldosterone biosynthesis. Alpha-1C subunit calcium channel (CC) (CaV1.2) is the specific target of anti-hypertensive CC blockers (CCBs) and its Alpha-1D subunit (CaV1.3) regulates depolarization of cell membrane in aldosterone-producing cells. Direct effects of CCBs on aldosterone biosynthesis were previously postulated but their intra-adrenal distribution and effects on steroid production in primary aldosteronism (PA) patients have remained virtually unknown. In this study, frozen tissue specimens constituting tumor, adjacent adrenal gland and peri-adrenal adipose tissues of nine aldosterone-producing adenoma (APA) cases were examined for visualization of amlodipine and aldosterone themselves using matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI). Liquid chromatog.-mass spectrometry (LC-MS) anal. was also performed to quantify amlodipine and 17 adrenal steroids in those cases above and compared the findings with immunohistochem. anal. of steroidogenic enzymes and calcium channels (CaV1.2 and CaV1.3). Effects of amlodipine on mRNA level of aldosterone biosynthetic enzymes were also explored using human adrenocortical carcinoma cell line (H295R). Amlodipine-specific peak (m/z 407.1 > 318.1) was detected only in amlodipine treated cases. Accumulation of amlodipine was marked in adrenal cortex compared to peri-adrenal adipose tissues but not significantly different between APA tumors and adjacent adrenal glands, which was subsequently confirmed by LC-MS quantification. Intra-adrenal distribution of amlodipine was generally consistent with that of CCs. In addition, quant. steroid profiles using LC-MS and in vitro study demonstrated the lower HSD3B activities in amlodipine treated cases. Immunoreactivity of CaV1.2 and HSD3B2 were also correlated. We report the first demonstration of specific visualization of amlodipine in human adrenal tissues by MALDI-MSI. Marked amlodipine accumulation in the adrenal glands suggested its direct effects on steroidogenesis in PA patients, possibly targeting on CaV1.2 and suppressing HSD3B activity.

Journal of Steroid Biochemistry and Molecular Biology published new progress about 21829-25-4. 21829-25-4 belongs to pyridine-derivatives, auxiliary class Membrane Transporter/Ion Channel,Calcium Channel, name is Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, and the molecular formula is C17H18N2O6, Recommanded Product: Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate.

Referemce:
https://en.wikipedia.org/wiki/Pyridine,
Pyridine | C5H5N – PubChem

Duan, Jingli published the artcileBioequivalence of domestic and imported betahistine mesylate tablets in healthy volunteers, Product Details of C10H20N2O6S2, the publication is Zhongguo Linchuang Yaolixue Zazhi (2003), 19(1), 42-45, database is CAplus.

The objective of this study was to determine the bioequivalence of domestic and imported betahistine mesylate in 20 healthy volunteers. A single dose of 24 mg domestic and imported betahistine mesylate tablets was given according to an open randomized 2-way crossover design. Plasma concentration of the main metabolite of betahistine, pyridine-2-ethanoic acid, was determined by HPLC/MS/MS method. The pharmacokinetics parameters of the two products were as follow: C_max 308.6 ± 208.8 mg L^-1 and 339.4 ± 213.4 mg L^-1; t_max 1.13 ± 0.66 h and 0.98 ± 0.47 h; AUC_0-t 1168.5 ± 794.9 mg L^-1 and 1129.3 ± 725.2 mg L^-1; AUC_0-∞ were 1213.2 ± 819.2 mg L^-1 and 1178.9 ± 752.5 mg L^-1, resp. The relative bioavailability of domestic product was (106.3 ± 29.1%). The results demonstrated that the two formations were bioequivalent by anal. of variance, two-one side test and 90% internal confidence.

Zhongguo Linchuang Yaolixue Zazhi published new progress about 54856-23-4. 54856-23-4 belongs to pyridine-derivatives, auxiliary class Pyridine,Salt,Amine,Inhibitor,Inhibitor, name is N-Methyl-2-(pyridin-2-yl)ethan-1-amine dimethanesulfonate, and the molecular formula is C10H20N2O6S2, Product Details of C10H20N2O6S2.

Referemce:
https://en.wikipedia.org/wiki/Pyridine,
Pyridine | C5H5N – PubChem

Jahed, Zeinab published the artcileNanocrown electrodes for parallel and robust intracellular recording of cardiomyocytes, Recommanded Product: Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, the publication is Nature Communications (2022), 13(1), 2253, database is CAplus and MEDLINE.

Drug-induced cardiotoxicity arises primarily when a compound alters the electrophysiol. properties of cardiomyocytes. Features of intracellular action potentials (iAPs) are powerful biomarkers that predict proarrhythmic risks. In the last decade, a number of vertical nanoelectrodes have been demonstrated to achieve parallel and minimally-invasive iAP recordings. However, the large variability in success rate and signal strength have hindered nanoelectrodes from being broadly adopted for proarrhythmia drug assessment. In this work, we develop vertically-aligned nanocrown electrodes that are mech. robust and achieve > 99% success rates in obtaining intracellular access through electroporation. We validate the accuracy of nanocrown electrode recordings by simultaneous patch clamp recording from the same cell. Finally, we demonstrate that nanocrown electrodes enable prolonged iAP recording for continual monitoring of the same cells upon the sequential addition of four incremental drug doses. Our technol. development provides an advancement towards establishing an iAP screening assay for preclin. evaluation of drug-induced arrhythmogenicity.

Nature Communications published new progress about 21829-25-4. 21829-25-4 belongs to pyridine-derivatives, auxiliary class Membrane Transporter/Ion Channel,Calcium Channel, name is Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, and the molecular formula is C17H18N2O6, Recommanded Product: Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate.

Referemce:
https://en.wikipedia.org/wiki/Pyridine,
Pyridine | C5H5N – PubChem

Thomas, K. V. published the artcileThe environmental fate and behaviour of antifouling paint booster biocides: A review, Related Products of pyridine-derivatives, the publication is Biofouling (2001), 17(1), 73-86, database is CAplus.

A review with references Antifouling paint booster biocides are a group of organic compounds added to antifouling paints to improve their efficacy. They have become prevalent since the requirement for alternative antifouling paints formulations for small boats (<25m). This need followed a ban on the use of triorganotin biocides in antifouling paints for small boats, in the late 1980’s. Worldwide, around eighteen compounds are currently used as antifouling biocides, viz. benzmethylamide, chlorothalonil, copper pyrithione, dichlofluanid, diuron, fluorofolpet, Irgarol 1051, Sea-Nine 211, Mancozeb, Polyphase, pyridine-triphenylborane, TCMS (2,3,5,6-tetrachloro-4-methylsulfonyl pyridine), TCMTB [2-(thiocyanomethylthio)benzothiazole], Thiram, tolylfluanid, zinc pyrithione (ZPT), ziram and Zineb. Any booster biocide released into the environment is subjected to a complex set of processes. These processes include transport mechanisms, transformation, degradation, cross media partitioning, and bioaccumulation. This paper reviews the fate and behavior data currently available in the public domain concerning antifouling paint booster biocides.

Biofouling published new progress about 971-66-4. 971-66-4 belongs to pyridine-derivatives, auxiliary class Pyridine,Benzene, name is Triphenyl(pyridin-1-ium-1-yl)borate, and the molecular formula is C5H5F3O2, Related Products of pyridine-derivatives.

Referemce:
https://en.wikipedia.org/wiki/Pyridine,
Pyridine | C5H5N – PubChem

Torssell, Kurt published the artcilePositive halogen compounds. VI. Preparation of alkoxydimethylsulfonium salts and their role in the Kornblum oxidation. Revision of the structure for the olefin-bromotrinitromethane adduct, Quality Control of 971-66-4, the publication is Acta Chemica Scandinavica (1947-1973) (1967), 21(1), 1-14, database is CAplus.

cf. CA 63: 6839b; 65: 19963b. Structure I for the reaction product of BrC(NO2)3 and cyclohexene was revised to II (R = 2-trans-bromocyclohexyl) (III). Treatment of 0.2 g. III in 1 ml. EtOAc with 0.2 g. NaBPh4 gave ROS+Me2B-Ph4 (IV, R = 2-bromocyclohexyl) (V), m. 138-40° (decomposition). III (0.2 g.) was heated with 1 ml. iso-BuOH at 55-6° 45 min. and treated with 0.2 g. NaBPh4 in 1 ml. EtOAc to give 0.19 g. IV (R = iso-Bu) (VI) m. 141-3° (decomposition). ClCO2Bu-iso prepared from 0.16 g. iso-BuOH and a slight excess of COCl2 (10% in ether) was treated, after evaporation of ether, with 1 ml. Me2SO and, after 0.5 hr., 0.7 g. NaBPh4 in 6 ml. 1:1 MeOH-water mixture to give 0.4 g. IV (R = Et), m. 150-60°, remelts ∼260°. III (1 g.) in 4 ml. MeOH kept at 40-50° 20 min., evaporated to half volume in vacuo, and treated with 10 ml. CCl4 to give 0.55 g. II (R = Me). II (R = Me) (0.25 g.) in 1 ml. MeOH was treated with 0.4 g. NaBPh4 in 1 ml. MeOH to give 0.38 g. IV (R = Me) (VII). Me2SO (0.3 g.) was mixed with 0.5 g. Me2SO4, kept at room temperature 24 hrs., treated with 0.75 g. KC(NO2)3 in 5 ml. dimethoxyethane, filtered from KMeSO4, concentrated to 0.5 volume in vacuo, and treated with 10 ml. CCl4 to give 0.3 g. VII, m. 51-2° (decomposition). Treatment of a mixture of 0.5 g. Me2SO4 and 0.3 g. Me2SO with 1.4 g. NaBPh4 in 10 ml. MeOH gave 0.9 g. VII. A bromonium ion (VIII) is suggested. VII (0.2 g.) was heated to 190° in a small bulb tube until gas evolution ceased (∼10 min.) to give 40 mg. condensate composed of benzene and MeOCH2SMe (ir and N.M.R.); the remainder was partially crystalline and gave Ph3BOSMe2 (IX), m. 160-3°. IX can also be obtained by addition of 0.1 ml. concentrated HCl to 0.2 g. NaBPh4 in 2 ml. water. Treatment of 50 mg. IX in 3 ml. EtOAc with 50 mg. pyridine gave Ph3BQ (Q = 1-pyridyl), m. 210° (decomposition), which was also obtained by Pfitzner-Moffat oxidation Pyrolysis of V at 130-40° 5 min. gave mostly benzene and a small amount IX, and pyrolysis of V in Me2SO gave a somewhat higher yield of carbonyl compounds and trans-2-bromocyclohexanol. Thus, the Kornblum oxidation and Barton’s modification (CA 61: 2958e) proceeds via an intermediary sulfonium ion, which collapses to a carbonyl compound and Me2S either by the reaction (1) or a cyclic mechanism (2), giving Me2S and CD3SCD2H when Me2CHCH2OS+(CD3)2B-Ph4 was pyrolyzed. The oxidation follows the mechanism (1) only if the α-proton is activated as in p-BrC6H4COCH2OS+Me2. A mechanism (3) for Pfitzner and Moffat oxidation (CA 64: 6709g) was suggested to proceed via a complex (X). Magnetic nonequivalence for S-methyl resonance peak of V (a doublet, separation 1.7 Hz.) was found. N.M.R. spectrum of VII or II (R = Me) underwent a drastic change when the compounds were heated in (CD3)2SO at 65°. After 1 hr., the absorption of SMe at δ = 3.29 disappeared and a new peak appeared at δ = 2.57 ppm. The peak at δ = 3.97 ppm. had the same intensity as before and only traces of Me2S were detected. The result suggested a carbonium ion exchange (4) comparable with proton exchange in water. The reaction is completely reversible because when XI was dissolved in Me2SO, VII was regenerated. Addition of NaI to VII gave a rapid change of spectrum showing a reaction, Me2SO+Me + NaI → Me2SO + MeI + Na+. Pyrolysis of VII to MeOCH2SMe resembles the Pummerer rearrangement.

Acta Chemica Scandinavica (1947-1973) published new progress about 971-66-4. 971-66-4 belongs to pyridine-derivatives, auxiliary class Pyridine,Benzene, name is Triphenyl(pyridin-1-ium-1-yl)borate, and the molecular formula is C10H10CoF6P, Quality Control of 971-66-4.

Referemce:
https://en.wikipedia.org/wiki/Pyridine,
Pyridine | C5H5N – PubChem

Updegraff, D. M. published the artcileTriarylborane complexes, a new series of broad-spectrum germicides, Application of Triphenyl(pyridin-1-ium-1-yl)borate, the publication is Journal of Infectious Diseases (1964), 304-10, database is CAplus.

More than 100 coordination complexes of triarylboranes with amines and substituted phosphines were screened against bacteria and fungi, and selected members were also screened against protozoa. The chem. stable complexes of triphenylborane and tris(para-substituted phenyl)borane were powerful broad-spectrum germicides, fungicides, and protozoicides.

Journal of Infectious Diseases published new progress about 971-66-4. 971-66-4 belongs to pyridine-derivatives, auxiliary class Pyridine,Benzene, name is Triphenyl(pyridin-1-ium-1-yl)borate, and the molecular formula is C19H22BNO5, Application of Triphenyl(pyridin-1-ium-1-yl)borate.

Referemce:
https://en.wikipedia.org/wiki/Pyridine,
Pyridine | C5H5N – PubChem

Yu, Weiqun published the artcileReviving Cav1.2 as an attractive drug target to treat bladder dysfunction, Name: Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, the publication is FASEB Journal (2022), 36(1), e22118, database is CAplus and MEDLINE.

A review. Inhibition of bladder contraction with antimuscarinics is a common approach to treat bladder hyperactivity, and the L-type voltage-gated calcium channel α1C (Cav1.2) is crucial for bladder contractility. Therefore, strategies aimed at inhibiting Cav1.2 appear warranted. However, multiple clin. trials that attempted to treat bladder overactivity with calcium channel blockers (CCBs) have been unsuccessful, creating an unsolved mystery. In contrast, cardiologists and epidemiologists have reported strong associations between CCB use and bladder hyperactivity, opposing expectations of urologists. Recent findings from our lab offer a potential explanation. We have demonstrated that ketamine which can cause cystitis, functions, like nifedipine, as a Cav1.2 antagonist. We also show that a Cav1.2 agonist which potentiates muscle contraction, rather than antagonizing it, can increase the volume of voids and reduce voiding frequency. This perspective will discuss in detail the unsuccessful urol. trials of CCBs and the promise of Cav1.2 agonists as potential novel therapies for bladder dysfunctions.

FASEB Journal published new progress about 21829-25-4. 21829-25-4 belongs to pyridine-derivatives, auxiliary class Membrane Transporter/Ion Channel,Calcium Channel, name is Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, and the molecular formula is C16H20N2, Name: Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate.

Referemce:
https://en.wikipedia.org/wiki/Pyridine,
Pyridine | C5H5N – PubChem

Chen, Hong-hua published the artcileEfficacy of manual reduction combined with betahistine mesylate in treatment of benign paroxysmal positional vertigo, SDS of cas: 54856-23-4, the publication is Xiandai Zhenduan Yu Zhiliao (2017), 28(7), 1235-1236, database is CAplus.

To explore the efficacy of manual reduction combined with drugs in the treatment of 60 cases of benign paroxysmal positional vertigo. Patients who were diagnosed with benign paroxysmal positional vertigo in our hospital from Feb. 2013 to Jan. 2015 were collected and randomly divided into a study group and a control group. The basic treatment of the two groups was manual reduction, and the study group was treated with betahistine mesylate tablets. The therapeutic effects of the two groups were compared for benign paroxysmal positional vertigo. The two groups were scored by the Vertigo Disorder Rating Scale before and after treatment. The therapeutic effects of the study group and the control group for benign paroxysmal positional vertigo were 100% and 66.7%, resp., and there was a difference (P < 0.05). The study group and the control group had no difference in the scores of the Vertigo Disorder Rating Scale before treatment (P > 0.05). There was a difference in the scores of the vertigo disorder rating scale between the study group and the control group after treatment (P < 0.05). This article believes that manual reduction combined with drugs has a definite effect in the treatment of benign paroxysmal positional vertigo and can significantly improve the symptoms of patients.

Xiandai Zhenduan Yu Zhiliao published new progress about 54856-23-4. 54856-23-4 belongs to pyridine-derivatives, auxiliary class Pyridine,Salt,Amine,Inhibitor,Inhibitor, name is N-Methyl-2-(pyridin-2-yl)ethan-1-amine dimethanesulfonate, and the molecular formula is C10H20N2O6S2, SDS of cas: 54856-23-4.

Referemce:
https://en.wikipedia.org/wiki/Pyridine,
Pyridine | C5H5N – PubChem